Abundant Neurogenesis Found in Adult Humans’ Hippocampi

Researchers identified thousands of immature neurons in the brain region, countering a recent result showing little, if any, signs of neurogenesis.

Written byAshley Yeager
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

A comparison of stained neural progenitors (pink) in a young (left) and old (right) brainCOURTESY OF MAURA BOLDRINIAdult human hippocampi are home to thousands of immature neurons, researchers report today (April 5) in Cell Stem Cell. The result runs counter to a paper published last month in Nature that found no evidence of neural precursor cells or immature neurons in adults. Such contradictory findings raise questions about researchers’ understanding of neurogenesis in human adult hippocampi, which are central to learning and memory.

“There’s been a long-standing debate about adult human neurogenesis,” Xinyu Zhao, a neurobiologist at the University of Wisconsin-Madison who was not involved in either study, tells The Scientist. She says the latest work in Cell Stem Cell is notable because it uses stereology—the gold standard of neurogenesis studies in animals—to count immature and mature neurons in the hippocampi of healthy humans. Stereology can determine the number of individual cell types in tissue, even when the sample has been sliced into sections.

“I have never seen anybody do this in human tissue because availability of human tissue is a major problem,” Zhao says. “The fact they did this counting on the whole hippocampal tissue is remarkable.”

We dispute the interpretation of their cellular staining experiments as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies